Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/11/21
Spero Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021GlobeNewsWire • 11/03/21
Spero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/28/21
Spero Therapeutics Submits New Drug Application to U.S. FDA for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including PyelonephritisGlobeNewsWire • 10/28/21
Spero Therapeutics Inks Revenue Interest Financing Agreement With HealthCare Royalty PartnersBenzinga • 09/30/21
Spero Therapeutics Enters Into a Non-Dilutive Revenue Interest Financing Agreement With HealthCare Royalty Partners® for Up to $125 MillionGlobeNewsWire • 09/30/21
Here's Why Momentum Investors Will Love Spero Therapeutics, Inc. (SPRO)Zacks Investment Research • 08/31/21
Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/07/21
Spero Therapeutics Announces Second Quarter 2021 Operating Results and Provides Business UpdateGlobeNewsWire • 08/05/21
Spero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/29/21
Spero Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021GlobeNewsWire • 07/29/21
Spero Therapeutics to Present at the Ladenburg Thalmann Healthcare ConferenceGlobeNewsWire • 07/07/21
Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia TerritoriesPRNewsWire • 07/05/21
Spero Therapeutics Stock Surges On $40M Equity Funding, SPR206 Licensing Pact With PfizerBenzinga • 07/01/21
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206GlobeNewsWire • 06/30/21
Spero Therapeutics Announces the Initiation of Bronchoalveolar Lavage and Renal Impairment Clinical Trials of SPR206GlobeNewsWire • 06/15/21